Purpose

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Condition

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
No

Criteria

Inclusion Criteria:

- Planned treatment with radiation therapy

- Ability to understand and sign IRB approved consent

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Treatment with Radiation Therapy Includes 16 different arms to capture patient data by disease site
  • Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
    Outcomes Tracking

Recruiting Locations

Mayo Clinic
Scottsdale, Arizona 85259-5499
Contact:
Clinical Trials Office - All Mayo Clinic Locations
855-776-0015 (toll free)

California Protons Cancer Therapy Center
San Diego, California 92121
Contact:
Alexandra Crawford, MPH
858-549-7431
alexandra.crawford@californiaprotons.com

South Florida Proton Therapy Institute
Delray Beach, Florida 33484
Contact:
Salina Ramirez
561-323-6360
sramirez@sfpti.com

Ackerman Cancer Center
Jacksonville, Florida 32223
Contact:
Mitchell Urmann
904-880-5522
mitchellu@ackermancancer.com

Miami Cancer Institute
Miami, Florida 33176
Contact:
Alex Kudryashev
786-596-2000
alexku@baptisthealth.net

Orlando Health Cancer Institute
Orlando, Florida 32806
Contact:
Leila IP, BSN, RN
321-843-3762
leila.ip@orlandohealth.com

Emory Proton Therapy Center
Atlanta, Georgia 30308
Contact:
Leann Schilling, MPH, CCRP
404-686-0286
leann.schilling@emory.edu

Northwestern Medicine Chicago Proton Center
Warrenville, Illinois 60555
Contact:
Don Smith, MS, CCRC
630-933-7820
donald.smith3@nm.org

University of Kansas Proton Therapy Center
Kansas City, Kansas 66160
Contact:
Amanda Schroeder
913-588-1617
aschroeder3@kumc.edu

Kansas City Proton Institute
Overland Park, Kansas 66207
Contact:
Judy Searcy
913-647-4173
jsearcy@kcuc.com

Willis-Knighton Cancer and Proton Therapy Center
Shreveport, Louisiana 71103
Contact:
Briana Barrow, CCRC
318-212-8671
bbarrow@wkhs.com

Maryland Proton Treatment Center
Baltimore, Maryland 21201
Contact:
Caitlin Eggleston
410-328-7586
caitlineggleston@umm.edu

McLaren Proton Therapy Center
Flint, Michigan 48532
Contact:
Drita Nuculovic
810-342-5674
drita.nuculovic@mclaren.org

Washington University in St. Louis
Saint Louis, Missouri 63110
Contact:
Lindsey Mayer, CCRP
314-286-2006
lindseymayer@wustl.edu

ProCure Proton Therapy Center
Somerset, New Jersey 08873
Contact:
Heba Darwish
732-357-2676
heba.darwish@nj.procure.com

New York Proton Center
New York, New York 10035
Contact:
Ryan Holder
646-968-9055
rholder@nyproton.com

University of Cincinnati Medical Center
Cincinnati, Ohio 45044
Contact:
Christine Vollmer, MBA
513-213-3203
mccordce@ucmail.uc.edu

Oklahoma Proton Center
Oklahoma City, Oklahoma 73142
Contact:
Jenny Washington, BSRT(T), CMD
405-773-6700
jenny.washington@okcproton.com

Tennessee Oncology Proton Center
Franklin, Tennessee 37067
Contact:
Erick Vides
615-716-4736
evides@tnonc.com

Thompson Proton Center
Knoxville, Tennessee 37909
Contact:
Kristi Simcox
865-331-4985
esimcox@covhlth.com

Inova Schar Cancer Institute
Fairfax, Virginia 22031
Contact:
Sangeetha Moturi
571-472-0343
sangeetha.moturi@inova.org

Hampton University Proton Therapy Institute
Hampton, Virginia 23666
Contact:
Donna Sternberg, RN, BSN, OCN
757-251-6839
donna.sternberg@hamptonproton.org

University of Washington
Seattle, Washington 98195-6043
Contact:
Erica Peters, CCRC, CPM
206-598-7188
etucker@uw.edu

More Details

NCT ID
NCT01255748
Status
Recruiting
Sponsor
Proton Collaborative Group

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.